Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1016/j.febslet.2012.02.017
Read article for free, from open access legal sources, via Unpaywall: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2012.02.017
References
Articles referenced by this article (33)
MicroRNA and hepatocellular carcinoma: biology and prognostic significance.
Minerva Gastroenterol Dietol, (3):257-271 2011
MED: 21769076
MicroRNAs in cell proliferation, cell death, and tumorigenesis.
Br J Cancer, (6):776-780 2006
MED: 16495913
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.
Br J Cancer, (8):1215-1220 2010
MED: 20842113
miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.
Biochem Biophys Res Commun, (3):586-592 2011
MED: 21763284
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
Cancer Res, (3):1135-1142 2009
MED: 19155302
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
Cancer Res, (13):6092-6099 2007
MED: 17616664
The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
Gut, (2):278-289 2011
MED: 21672940
MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.
Hepatology, (5):1731-1740 2010
MED: 20827722
Show 10 more references (10 of 33)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.febslet.2012.02.017
Article citations
Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma.
Mol Biol Rep, 50(9):7681-7691, 07 Jul 2023
Cited by: 3 articles | PMID: 37418086
Review
Plasma miRNA Profile of Crohn's Disease and Rheumatoid Arthritis Patients.
Biology (Basel), 11(4):508, 25 Mar 2022
Cited by: 3 articles | PMID: 35453708 | PMCID: PMC9033111
Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination.
J Clin Transl Hepatol, 10(4):608-619, 21 Feb 2022
Cited by: 4 articles | PMID: 36062277 | PMCID: PMC9396321
SALL4 and microRNA: The Role of Let-7.
Genes (Basel), 12(9):1301, 24 Aug 2021
Cited by: 6 articles | PMID: 34573282 | PMCID: PMC8467721
Review Free full text in Europe PMC
GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets.
Front Oncol, 10:537311, 04 Dec 2020
Cited by: 8 articles | PMID: 33344222 | PMCID: PMC7746843
Review Free full text in Europe PMC
Go to all (71) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Hepatology, 57(1):195-204, 01 Jan 2013
Cited by: 50 articles | PMID: 22865282
Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
J Gastroenterol Hepatol, 26(11):1630-1637, 01 Nov 2011
Cited by: 45 articles | PMID: 21557766
miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
FEBS Lett, 586(19):3309-3316, 20 Jul 2012
Cited by: 39 articles | PMID: 22819824
Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
FEBS J, 280(10):2471-2476, 31 Jan 2013
Cited by: 108 articles | PMID: 23305321
Review